High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer

Published:2012-06-28 Issue:6 Volume:7 Page:e39801
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Vainio Paula,Mpindi John-Patrick,Kohonen Pekka,Fey Vidal,Mirtti Tuomas,Alanen Kalle A.,Perälä Merja,Kallioniemi Olli,Iljin Kristiina

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference64 articles.

1. Global cancer statistics.;A Jemal;CA Cancer J Clin,2011

2. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.;IF Tannock;N Engl J Med,2004

3. Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells.;R Berger;Cancer Res,2004

4. Androgen receptor in prostate cancer. Endocr Rev 25: 276–308.;CA Heinlein,2004

5. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.;P Hååg;J Steroid Biochem Mol Biol,2005

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemopreventive effects of Sargassum cristaefolium against prostate cancer targeting p53-mediated apoptosis signaling pathway: An in vitro and in vivo study;Food Bioscience;2024-10

2. TMED2 promotes glioma tumorigenesis by being involved in EGFR recycling transport;International Journal of Biological Macromolecules;2024-03

3. Expression and prognostic value of AIM1L in esophageal squamous cell carcinoma;Medicine;2023-08-25

4. New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer;Molecular Therapy - Oncolytics;2023-06

5. Identification of the prognostic biomarkers and their correlations with immune infiltration in colorectal cancer through bioinformatics analysis and in vitro experiments;Heliyon;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3